The new drug, sold under the name Victoza and made by Hikma Pharmaceuticals USA Inc., follows the approval of the generic GLP-1 exanatide last month, sold under the name Byetta. Neither drug is ...

An icon in the shape of a lightning bolt. Impact Link Cadbury, a storied chocolate maker, has lost its royal warrant from the British monarchy for the first time in 170 years. The warrant, which ...

Her company, Creatio, offers a generative AI and no-code platform for workflow automation and CRM solutions, empowering businesses to build custom solutions without writing a single line of code.

The AirPods Pro 2 were released two years ago, and now thanks to a software update can be used to conduct a Medically Certified hearing test using an iPhone, and if needed the AirPods themselves ...

The nationwide survey, conducted from November 26 to December 3, showed that Marcos’ approval rating dropped to 48 percent from 50 percent in September. His trust rating also fell to 47 percent ...

Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration granted it Breakthrough Therapy Designation status that, if successful ...

The majority of the country’s top government officials saw a dip in their approval and trust ratings in November, according to a survey conducted by Pulse Asia and released on Saturday, Dec. 21.

President Biden’s approval rating slipped to the lowest its been since he took office in 2021, according to a new survey that was released Wednesday. The Marquette Law School Poll national ...

New polling released Tuesday showed President-elect Donald Trump's approval rating had surged since Election Day, while opposition voices had largely "melted away." The analysis for Newsweek by ...

It’s not an apples-to-apples comparison, but the level of approval today is sharply higher than eight years ago. The big—and significant—question is: Why? The easy and perhaps too obvious ...

The reality is that, while AI agents show great promise, they are not yet sophisticated enough to address enterprise workflows spanning multiple users and processes. We’re just scratching the ...